ZAGONEL, VITTORINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.610
EU - Europa 410
AS - Asia 322
SA - Sud America 5
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.353
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.607
CN - Cina 241
IT - Italia 187
FI - Finlandia 67
HK - Hong Kong 59
SE - Svezia 47
DE - Germania 35
GB - Regno Unito 32
IN - India 11
FR - Francia 8
UA - Ucraina 7
IE - Irlanda 6
BE - Belgio 5
NL - Olanda 5
VN - Vietnam 4
AU - Australia 3
CA - Canada 3
ES - Italia 3
CO - Colombia 2
EU - Europa 2
IR - Iran 2
SG - Singapore 2
AR - Argentina 1
AT - Austria 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
JP - Giappone 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.353
Salva come PNG Salva come JPEG
Città #
Fairfield 663
Chandler 500
Ashburn 320
Cambridge 264
Woodbridge 259
Seattle 254
Houston 228
Wilmington 191
Ann Arbor 167
San Diego 85
Beijing 82
Padova 74
Helsinki 60
Medford 59
Princeton 59
Des Moines 42
New York 27
Boardman 12
Los Angeles 12
Milan 12
London 11
Jinan 10
Nanjing 10
Guangzhou 9
Hefei 9
Venice 9
Kilburn 8
Washington 8
Dublin 6
Nanchang 6
Shenyang 6
Changsha 5
Ogden 5
Bozzolo 4
Chicago 4
Hebei 4
Kharkiv 4
Lappeenranta 4
Ningbo 4
Shanghai 4
Tianjin 4
Treviso 4
Córdoba 3
Fuzhou 3
Hounslow 3
Jiaxing 3
Naples 3
Pune 3
Rome 3
Rovigo 3
Tappahannock 3
Bogotá 2
Chongqing 2
Hanoi 2
Hanover 2
Ho Chi Minh City 2
Kraainem 2
Noventa 2
Redmond 2
Redwood City 2
Rovereto 2
Sant'Antimo 2
Sydney 2
Taizhou 2
Tehran 2
Trento 2
Varallo Pombia 2
Waanrode 2
Xian 2
Zhengzhou 2
Acton 1
Amsterdam 1
Asunción 1
Atlanta 1
Aversa 1
Avezzano 1
Bergamo 1
Borås 1
Bratislava 1
Brussels 1
Calgary 1
Canton 1
Cerano 1
Cesena 1
Chengdu 1
Chisinau 1
Chiswick 1
Ciampino 1
Deiva Marina 1
Delhi 1
Denver 1
Dolo 1
Elk Grove Village 1
Erding 1
Esslingen am Neckar 1
Etobicoke 1
Falkenstein 1
Falls Church 1
Ferrara 1
Filadelfia 1
Totale 3.603
Salva come PNG Salva come JPEG
Nome #
Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up 171
Class 1, 2 and 3 BRAF mutated metastatic colorectal cancer: a detailed clinical, pathological and molecular characterization 164
Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma 163
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155) 155
Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials 145
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 133
Immune senescence and immune activation in elderly colorectal cancer patients 130
An overview on clinical, pathological and molecular features of lung metastases from colorectal cancer 125
CK7 and consensus molecular subtypes as major prognosticators in V600E BRAF mutated metastatic colorectal cancer 123
Immunotherapy in Gastrointestinal Cancers 118
Immunotherapy in Gastrointestinal Cancers 107
null 103
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: A phase II study with pharmacokinetic analysis 102
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases 97
Multidisciplinary osteoncologic approach to bone metastases: Analysis of a large, mono-institutional cohort 94
Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma 92
Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study 91
Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study 90
Role of dose exposure and inflammatory status in a single center, real-world analysis of sunitinib in patients with metastatic renal cell carcinoma 89
Anaplastic Astrocytoma: State of the art and future directions 82
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 76
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab 75
mTOR pathway and somatostatin receptors expression intratumor-heterogeneity in ileal NETs 73
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status 72
Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer? 71
Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study 66
Discordance of IDH mutational status between lesions in an adult patient with multifocal glioma 64
Clinical management of diffuse low-grade gliomas 64
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 60
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 59
Outcome of patients with colorectal cancer undergoing lung metastases resection: a single-institution retrospective analysis 57
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives 56
Association of cldn18 protein expression with clinicopathological features and prognosis in advanced gastric and gastroesophageal junction adenocarcinomas 55
Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial 54
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study 52
Suspicious for recurrent low and high grade glioma and indeterminate MRI: the role of 18F-DOPA PET/CT 50
Extraskeletal Myxoid Chondrosarcoma: clinical and molecular characteristics and outcomes of patients treated at two Institutions 50
Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas 48
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction 47
IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients, a cohort study 46
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes 45
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib 43
Ocular Side Effects of EGFR-Inhibitor ABT-414 in Recurrent Glioblastoma: A Long-Term Safety Study 41
Mismatch-repair protein expression in high-grade gliomas: A large retrospective multicenter study 39
Periostin and epithelial-mesenchymal transition score as novel prognostic markers for leiomyosarcoma, myxofibrosarcoma, and undifferentiated pleomorphic sarcoma 38
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters 38
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases 37
High ETV6 Levels Support Aggressive B Lymphoma Cell Survival and Predict Poor Outcome in Diffuse Large B-Cell Lymphoma Patients 36
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial 36
The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors 35
A real-world application of liquid biopsy in metastatic colorectal cancer: The poseidon study 33
Synaptophysin expression in V600EBRAF-mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis 32
Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial 31
PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review 31
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study 29
Sustained accumulation of blood‐derived macrophages in the immune microenvironment of patients with recurrent glioblastoma after therapy 29
Other than restaging phase: serial FCH-PET/CT scans can predict the reponse to chemotherapy (CT) in castrate-resistant prostate cancer (CRPCa)? 27
Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients 27
An Overview of Intracranial Ependymomas in Adults 25
Phosphorylated acetyl-coa carboxylase is associated with clinical benefit with regorafenib in relapsed glioblastoma: REGOMA trial biomarker analysis 25
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study 23
Bone metastases from neuroendocrine tumors: clinical and biological considerations 23
Newly Diagnosed Multifocal GBM: A Monocentric Experience and Literature Review 20
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 17
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling 16
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care 16
Impressive response to dabrafenib and trametinib plus silybin in a heavily pretreated IDH wild-type glioblastoma patient with BRAFV600E-mutant and SOX2 amplification 14
Impact of Gastrointestinal Side Effects on Patients' Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study 14
Renal cell carcinoma: the population, real world, and cost-of-illness 13
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 12
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation 11
Pros-IT CNR: an Italian prostate cancer monitoring project 11
Trabectedin and Radiation Therapy for Cardiac Metastasis From Leiomyosarcoma: A Case Report and Review of the Literature 9
Trabectedin and Radiation Therapy for Cardiac Metastasis From Leiomyosarcoma: A Case Report and Review of the Literature 4
The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study 3
Totale 4.452
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.421
article - articoli 21.421
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.842
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019131 0 0 0 0 0 0 0 0 0 0 65 66
2019/20201.004 50 35 48 285 67 42 91 91 118 79 56 42
2020/2021672 35 67 30 37 45 23 40 106 72 98 89 30
2021/2022990 54 73 59 58 63 109 109 83 90 30 60 202
2022/2023987 154 123 28 134 93 92 37 64 189 24 38 11
2023/2024531 16 103 72 51 57 101 72 19 17 22 1 0
Totale 4.452